Congenital heart defects (CHDs) are the most common cause of childhood morbidity and early mortality. Prenatal detection of the underlying molecular mechanisms of CHDs is crucial for inventing new preventive and therapeutic strategies. Mutant mouse models are powerful tools to discover new mechanisms and environmental stress modifiers that drive cardiac development and their potential alteration in CHDs. However, efforts to establish the causality of these putative contributors have been limited to histological and molecular studies in non-survival animal experiments, in which monitoring the key physiological and hemodynamic parameters is often absent. Live imaging technology has become an essential tool to establish the etiology of CHDs. In particular, ultrasound imaging can be used prenatally without surgically exposing the fetuses, allowing maintaining their baseline physiology while monitoring the impact of environmental stress on the hemodynamic and structural aspects of cardiac chamber development. Herein, we use the High-Frequency Ultrasound (30/45) system to examine the cardiovascular system in fetal mice at E18.5 in utero at the baseline and in response to prenatal hypoxia exposure. We demonstrate the feasibility of the system to measure cardiac chamber size, morphology, ventricular function, fetal heart rate, and umbilical artery flow indices, and their alterations in fetal mice exposed to systemic chronic hypoxia in utero in real time.
Introduction
Congenital malformations of the heart are heterogeneous structural defects that occur during early cardiac development. Current technical advances of operational procedures have led to significant improvements in the survival rates of infants with CHDs 1, 2 . However, quality of life is often compromised secondary to prolonged hospitalization and needs for staged surgical repair procedures 1, 2, 3, 4, 5 . Prenatal detection of the underlying molecular mechanisms of CHDs is crucial in order to plan early interventions, to carry out new prevention strategies, and to improve the lifelong outcomes 6, 7 .
Although multiple genetic and environmental factors have been implicated in CHDs pathogenesis, establishing the causality remains an unmet need to improve diagnostic, therapeutic, and preventive strategies 1, 8, 9, 10, 11, 12 . Furthermore, examining the roles of in utero stress factors and epigenetic modifiers opens new venues for future investigations 11, 12 . The last decade has indeed witnessed rapid advances in next generation sequencing technology including single nucleotide polymorphism (SNP) microarray, whole exome sequencing, and genome-wide methylation studies, their utilization in studying the genetic causes of complex human diseases, including CHDs 1, 8, 9, 10, 11 paving the way to identify novel mutations and genetic variants that have not yet been tested for their pathogenicity in suitable animal models.
Among the different disease model systems, mouse is the animal model of choice, not only for investigating mechanisms of CHDs during early cardiogenesis 13, 14, 15, 16 , but also to elucidate their impact on cardiac chamber maturation and function at late gestation in prenatal and perinatal stress factors. Hence, performing in vivo phenotypic characterization of a mutant fetal mouse heart, during both early and late stages of development, is crucial to understand the role of these genetic variations and environmental factors on cardiac development, and the potential future impact on chamber specific maturation processes in mice.
Early detection and accurate diagnosis of cardiac defects during development is critical for interventional planning 17, 18 . Being safe, simple, portable and repeatable, fetal sonography has indeed become the standard imaging technique for cardiac evaluation in the clinic. Fetal circulation assessment using Doppler ultrasound has been widely used in clinical practice not only for the detection of cardiac defects, but also to detect vascular abnormalities, placenta insufficiency and intrauterine growth restriction, and to assess the fetal well-being in response to in utero insults including hypoxemia, maternal illness, and drug toxicity 17, 18 . In parallel to its value in evaluating human defects and diseases, ultrasound assessment of fetal mice has gained increasing utility in experimental settings 19, 20, 21, 22, 23 1. Apply pre-warmed ultrasound gel on the abdomen and spread it carefully to avoid bubble formation. Add additional amount of gel on the area of scan imaging. 2. Place the ultrasound probe on its mechanical holder and mobilize it gradually towards the skin to contact with the thick gel layer while looking for the beating heart using the scanning B-Mode (Figure 1 ). 3. Click the scanning B mode button to obtain 2-D images. Use the bladder as a landmark to identify the first fetus positioned in the right or the left uterine horn and mark it as R1 or L1, respectively. 4. Confirm the right and left orientation of the individual fetus in real time by moving the imaging platform in the horizontal plane. Scan from head to tail to annotate the snout, the limbs, and the spine as landmarks ( Figure 1B , Video 1). 5. Visualize the beating heart and annotate the left ventricle (LV) and the right ventricle (RV). Use color Doppler mode to optimize the heart visualization ( Figure 1 C-G, Videos 1-2). 6. Click the scanning B mode button to obtain a parasternal short axis-view, have the LV and RV displayed in their maximum diameter at the center of data acquisition frame. Start live imaging (Figure 1B-C) . 7. Change the orientation of the mouse with respect to scanning planes to obtain a longitudinal four-chamber view ( Figure 1D) . First, identify the remaining structures of the heart such as the atria, interventricular septum, and left and right outflow tracts. Next, have the ventricular and atrial chambers displayed in their maximum diameter. Then start image acquisition. 8. Exclude the non-optimal, oblique images from the final analysis. Click the Cini button to obtain continuous recording 'Cineloops' for a minimum of 10 s, then save the recorded images. 
Evaluating Fetal Heart Rate and Ventricular Function

Evaluating the Feto-Placental Axis
1. Use the color Doppler scan to visualize the uterine artery and feto-placental vascular tree by using the 45 MHz transducer ( Figure 4A ). 2. Identify the umbilical vessels (two arteries and one vein) in the intra-amniotic segment of the umbilical cord, just after the cord exits from the fetal abdomen. 3. Place pulsed wave Doppler sample volume to obtain the umbilical artery flow pattern (Figure 4A ). 4. Measure vascular peak flow parameters including acceleration time (AT), ejection time (ET), and peak flow velocity at end systole (PkV, s) using the pulsed wave Doppler scanning record ( Figure 4B ). 5. Obtain 5 consecutive waveforms in each vessel, in the absence of fetal movements and maternal respiratory movements, to measure the average peak velocity for each vessel. 6. Proceed to the next embryo.
Post-Imaging Animal Monitoring
1. Turn off the isoflurane container following the completion of the imaging process. 2. Continue monitoring body temperature, respiratory rate, and heart rate during the recovery phase. 3. Remove the facemask and the connected tubing system once the dam starts spontaneous movements. 4. Return the dam to the appropriate housing and continue observation according to standard institutional post-procedure protocols. 5. Document the time to full resumption of normal activity.
Performance Requirements and Technical Considerations
1. Limit the processing time for ~8 fetuses to approximately 1 h to avoid the adverse effects of prolonged anesthesia on vital signs and physiological parameters. 2. Complete training with 8-10 pregnant mice to optimize techniques for image acquisition and flow patterns tracing in a short time frame.
Representative Results
Statistical analyses of cardiac and hemodynamic indices were performed offline. The means of 5 consecutive measurements in 3 optimal images were calculated. The data were expressed as Mean ± SEM. Student's t-test was used to infer intergroup comparisons. A P value of ≤0.05 was considered statistically significant.
Following the above protocol, we characterized the impact of chronic exposure to prenatal hypoxia on the cardiovascular status of fetal mice at late gestation by obtaining real-time high frequency ultrasound recordings on the C57/BL6 timed pregnant mice at gestational day (GD) 18.5.
After establishment of breeding groups, successful mating was confirmed. Timed pregnant dams were maintained in cages under a 12 h lightdark regime with food and water ad libitum until. At GD14.5, the pregnant mice were either allocated to the normoxia group (maintained in ambient air) or to the hypoxia group (placed in hypoxia chamber at 10% FiO 2 to induce systemic hypoxia). After birth, the dams and their pups remained allocated to their experimental condition until postnatal day 7 (P7).
In total, 6 dams were studied in these experiments and 42 fetuses were successfully imaged at GD18.5. Of these, data obtained from 36 fetuses were used for subsequent analysis ( Table 1) . Analysis of fetal heart rates at GD18.5 showed that hypoxic fetuses suffered from fetal bradycardia (lower heart rates) and experienced significant decline of fetal cardiac function indices (EF% and FS%) ( Table 1) . Remarkably, peak flow velocities (PkVs) of the umbilical artery PkVs were decreased in hypoxia-exposed fetuses ( Figure 4B and Table 1 ). Furthermore, the umbilical artery acceleration time/ejection time (AT/ET) ratios revealed significantly lower values in the hypoxic compared to the normoxic fetuses, suggesting increased umbilical vascular flow resistance. In agreement, right ventricular wall thickness was increased in hypoxia-exposed fetuses as measured on 2-D/M-mode images (Figure 5 ). Since the RV assumes dominant pump function during fetal development, while the placenta serves as the primary vascular bed for oxygenation, these data collectively suggest elevated flow resistance in the feto-placental vascular circuit leading to RV hypertrophy. Importantly, hypoxia exposed newborns faced early postnatal lethality. RV failure and increased vascular resistance induced by chronic exposure to prenatal hypoxia are potentially contributing cause. Other factors, such as redox toxicity resulting from reoxygenation injury, poor feeding, and maternal sickness cannot be excluded. Nevertheless, the exact underlying mechanism of prenatal hypoxia induced cardiac pathogenesis and the early lethality of the fetuses remain to be determined in future studies. . We have previously demonstrated a significant impact of maternal caloric restriction, initiated during the second trimester, on feto-placental circulatory flow and fetal cardiac function 9 .
Prenatal hypoxia is another common stress factor during fetal development that may tremendously affect the feto-placental physiology and circulatory system. The impact of prenatal hypoxia exposure may be more profound in the context of a CHD leading to poor perinatal adaptation to postnatal life. The abnormal heart rates and cardiac indices detected in this study are indeed important indicators of cardiac stress and altered placental circulatory physiology, and thus constitute essential primary elements for detecting the developmental defects and consequent hemodynamic alterations that may become further pronounced in response to prenatal hypoxic stress leading to early heart failure. Contrary to expectations, hypoxia exposed fetuses had lower heart rates. This phenomenon may reflect immature cardiac autoregulation mechanisms in fetal mice in response to hypoxia at GD18.5. However, the exact pathogenesis remains unknown.
Although other advanced imaging methods, such as fetal cardiac MRI, allow live imaging of cardiac structures during development 20 , the hemodynamic status is often lost due to static images and lengthy procedures. Noninvasive ultrasound technology, on the other hand, allows performing in vivo dynamic imaging that maintains the baseline physiology. Further, with the availability of high frequency transducers with enhanced resolution, the visualization of the fetal heart at different developmental stages of each individual fetus can become more feasible in transgenic mice by optimizing fetal annotation methods. Lastly, the cost per experiment is far less using this method.
In a previous report by Kim GH et al., the authors provided important and novel insights regarding imaging plan optimization for data acquisition by using a prior generation of high frequency ultrasound imaging system 21 . Another report by Zhou YQ et al., has established standardized baseline measurements of fetal circulation at the physiological level by using a high frequency ultrasound equipped with color Doppler system 22 . Hence, the protocol presented here complements previously established protocols, and expands to outline a comprehensive method that is feasible and practical in real time in an experimental setting. An advanced and highly sensitive high frequency ultrasound system was used in this study to scan the feto-placental circuit as a unit. The outlined protocol is simple and standardized to employ this powerful system effectively as demonstrated by achieving quantifiable measurements of hypoxia impact on fetal circulation in mice at GD18.5.
Nevertheless, we should acknowledge important limitations and challenges of fatal cardiac imaging: First, anesthetic agents, including isoflurane, may affect the physiologic parameters of the fetus. Prolonged anesthesia, hair loss, and ultrasonic gel can lead to hypothermia, which can affect the heart rate and hemodynamic indices of the dam as well as the fetuses. At present, there is no available method to evaluate the level of anesthetic agents and their impacts on the fetus. To circumvent this limitation, we titrate inhaled Isoflurane levels carefully to achieve appropriate sedation of the dams, while maintaining their basal heart rate and vital signs. Second, visualizing fetuses that are located deep in the abdomen is difficult and suboptimal, leading to exclusion of these fetuses from final data analysis. The color Doppler allows improved optimization of imaging sections and adequate alignment between the transducer and blood flow. Third, performing simultaneous analysis of all fetuses requires the operator's efficiency in rapid and accurate visualization and image acquisition rapidly, implying the importance of practical training.
Finally, key steps in this method need to be emphasized including 1) Proper preparation of the system. 2) Maintaining a stable body temperature and heart rate for the pregnant mouse. 3) Optimizing the flow rate of isoflurane to maintain baseline physiological states of the embryos to acquire reliable data. 4) Consistent and efficient image acquisition within the shortest time possible. 5) Gestational age, sex, and animal strain are important variables that may significantly affect the results. Therefore, the experimental protocol should be designed carefully to account for these variables by including matched controls from the same animal strain in data analysis and interpretation.
In conclusion, a high frequency ultrasound system is an effective method to achieve phenotypic characterization of fetal cardiovascular systems in utero with important experimental and scientific value and potential future applications that may include 1) Understanding the physiological dynamics during cardiac development. 2) Achieving comprehensive phenotypic analysis of genetic models of CHDs. 3) Elucidating the impact feto-placental circulation on cardiac chamber development, maturation, and adaptation to stress. 4) Performing ultrasound guided fetal injection
